SCOTTSDALE, Ariz. (AP) — From the pinstripes of New York all the way to the Dodger blues of Los Angeles, there is a strong ...

While destinations like Texas, Wyoming, and Tennessee might come to mind first, Ely, Nevada, is emerging as an unexpected ...

Within minutes after David Batts entered the Knox County jail on Jan. 7, Knox County sheriff's officers pepper-sprayed, shocked him with a Taser four times and punched him as they tried to get him ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

21 when police say he filmed himself spraying bug spray on produce inside of a Mesa, Arizona, Walmart. The 27-year-old faces two felony charges, including one count of burglary in the third degree ...

Now, a fully autonomous tractor drives through his expansive orchard, spraying pesticides and fertilizer to protect the trees that have for decades filled him with an immense sense of pride.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...